Skip to content

Management of Osteoarthritis with ayurveda

A Randomised Comparative Clinical Study to Evaluate the Efficacy of Paribhadradi pralepa and Paribhadradi ointment in the management of Janu Sandhigata Vata ( Knee Osteoarthritis) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076351
Enrollment
100
Registered
2024-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

None listed

Sponsors

Not sponsored
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group of 40 to 70 years of either sex. 2. Patients having signs and symptoms of Janusandhigata Vata of Shotha (edema), Vatapurnadriti Sparsha (on palpation revealed as air filled bag) and pain with Prasaran (extension) and Akunchan (flexion) movements. 3. Patients having chronicity of disease Janusandhigata Vata (KOA) for less than 5 years. 4. Patients willing to sign consent form for the clinical trial. 5. Kellgren Lawrence (Radiological scale) of e ? =2 13

Exclusion criteria

Exclusion criteria: 1. Patients below 40 years and above 70 years of age. 2. Patients of Rheumatoid arthritis, Ankylosing and traumatic arthritis. 3. Patients suffering from paralysis, muscular dystrophy, polio or bony deformities. 4. Patients having systemic conditions such as Tuberculosis, Brucellosis, Osteomyelitis, Gouty Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus 5. Patients having neoplasm of spine and other complicated diseases like CCF, DM, Uncontrolled HTN, Unstable Angina, Recent MI etc. 6. Patients using anti-inflammatory medicines including Allopathic medicine and AYUSH medicines.

Design outcomes

Primary

MeasureTime frame
The expected outcome of the study would ideally demonstrate the efficacy of both Paribhadradi Pralepa and Paribhadradi ointment in improving pain, functionality, and quality of life in patients with knee osteoarthritis, while also ensuring their safety and tolerability profile. Timepoint: 15 days

Secondary

MeasureTime frame
Reduction in hospital visits after completion of trialTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Chander Shekhar Sharma

Desh Bhagat Ayurvedic College and Hospital

drpawar57@yahoo.in7505039976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026